VineMeds, Inc Announces Appointment of Rich Wartel to Board of Directors
NAPLES, Florida, July 22, 2025 -- VineMeds Inc, a healthcare analytics company revolutionizing pharmaceutical channel management, today announced the appointment of Rich Wartel to the VineMeds Board of Directors. As a member of the Board of Directors, Mr. Wartel will also serve as a Strategic Advisor to the VineMeds senior management team.
“We are delighted to welcome Rich Wartel to our Board of Directors,“ said David Janca, Founder and Chairman of the Board for VineMeds, Inc. “Mr. Wartel brings extensive experience in business strategy, pharmaceutical supply chain planning and new product launch. His vast experience and extensive network will help the VineMeds’ management team unlock new value beyond compliance and maximize pharmaceutical product access and efficiency in our mission to leverage AI technologies and serialized data to transform the pharma supply chain.”
Mr. Wartel is the founder of Two Labs Pharma Services, a leading pharmaceutical consulting company that provides a portfolio of commercialization, payer strategy and market access services, where he served as the CEO from 2003 through 2020. Mr. Wartel has also served as Vice President at Cardinal Health, a multinational health care services and pharmaceutical distribution company from 1996 to 2003, and, from 1991 to 1996, as co-founder and Vice President of Purchasing at American Health Superstore, one of the first big box retailers of Home Healthcare in the US at the time.
“I am thrilled to join VineMeds’ Board of Directors,“ said Rich Wartel. “Dave Janca and the team at VineMeds were pioneers in establishing the current market for supply chain data and set for the bar for how our industry defines ‘data aggregation’ today. With their use of next generation AI technologies and their creative use of serialization data, VineMeds has uncovered a tremendous opportunity to further empower pharmaceutical supply chain stakeholders to recognize substantial value from their supply chain investments. I look forward to leveraging my experience in the industry, combined with the VineMeds management team’s track record for execution and delivery, to support VineMeds’ continued growth and long-term success.”
Since leaving Two Labs after their sale to Envision Pharma/GHO Capital Partners, Mr. Wartel has been committed to spending time with his family, assisting several non-profits and helping healthcare stakeholders better serve patients, supported by his latest organization, One Lab Innovations, Inc, with which he aims to change healthcare through assisting private equity in M&A, and developing his own ideas in partnership with others.
About VineMeds, Inc
At VineMeds, we're game-changers in pharmaceutical channel management, offering an AI-optimized platform that delivers unprecedented insights and data value. We are your trusted partner in managing legacy EDI data, while also providing a transition path to serialization data; the next generation in supply chain visibility and product optimization. VineMeds can help you eliminate assumptions and ensure no surprises in your operations. Our solutions dramatically increase efficiency, cutting time spent creating analytics by up to 50%. Using powerful AI capabilities, our platform helps you make informed decisions that drive ROI and ultimately improves patient services. We help you manage everything from eliminating returns and overstocks to optimizing pricing and matching supply with demand, all while being guided by industry experts dedicated to your success.
For more information, visit www.vinemeds.com.
Contact: VineMeds, Naples, Florida, 4501 Tamiami Trail N, Suite 226 Naples, FL 34103
Cameron Hall, 716-474-2995 (Media)
Conrad Morgiewicz, 978-549-1436 (Sales)
​
​​
​
​
​